Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes.

OBJECTIVES: Monopolar transurethral resection of the prostate (TURP) is the gold standard surgical treatment for bothersome moderate to severe lower urinary tract symptoms (LUTS) secondary to benign prostate obstruction. The aim of the study is to compare monopolar versus bipolar TURP focusing on operative and functional outcomes, and evaluating complications with a long-term follow-up. METHODS: From January 2007 to July 2014, a total of 497 patients were randomized and prospectively scheduled to undergo bipolar (251) or monopolar (246) TURP. International prostate symptom score (IPSS), IPSS-Quality of life (QoL), post-void residual and maximum flow rate were assessed preoperatively and postoperatively at 3, 12, 24 and 36 months. Operative time, length of catheterization and hospitalization were all recorded. Complications were classified and reported. RESULTS: All patients completed the 36-month follow-up visit. Perioperative results showed no statistical significance between the two groups in terms of catheterization days, post-void residual, IPSS, IPSS-QoL score. The hospitalization length was found statistically significant in favor of the bipolar group. The 3-, 12-, 24- and 36-month follow-up showed significant and equal improvements in LUTS related to BPO in the two treatment groups. Regarding TURP complications, significant differences were observed in relation to urethral strictures, blood transfusion and TUR syndrome in favor of the bipolar group. CONCLUSIONS: Monopolar and bipolar TURP are safe and effective techniques for BPH management. Bipolar TURP in our prospective study reported the same efficacy of monopolar prostate resection, with a significant reduction of related complications.

Non-invasive urodynamics predicts outcome prior to surgery for prostatic obstruction.

OBJECTIVE: To assess whether the penile cuff non-invasive urodynamic test serves as an effective diagnostic tool for predicting outcomes prior to disobstructive surgery for men presenting with voiding lower urinary tract symptoms. Patients with proven urodynamic obstruction do better after surgery. The current gold standard, invasive pressure-flow studies, imposes cost, resource demand, discomfort and inconvenience to patients. PATIENTS AND METHODS: Patients undergoing surgery for prostatic obstruction at Palmerston North Hospital had pre-operative non-invasive urodynamics and completed an International Prostate Symptom Score (IPSS). Catheterised patients were excluded. Two months post-operatively they completed a further IPSS score. An improvement of seven or greater was defined as a clinically successful outcome. Results were compared with the outcome predicted by the nomogram supplied with the urodynamic device. RESULTS: Data was obtained for 62 patients with mean age 70 years (range 49 to 86 years; SD 9 years). Follow-up was complete for all patients. Thirty-eight patients underwent transurethral resection and 24 holmium laser enucleation of the prostate. Mean IPSS score was 21 (range 5 to 35; SD 6) pre-operatively and 11 (range 1 to 31; SD 9) post-operatively. Thirty-five patients were predicted obstructed and 27 not obstructed. 94% of those predicted obstructed had a successful outcome (p < 0.01). 70% predicted as not obstructed did not have a successful outcome after surgery (p < 0.01). CONCLUSION: The penile cuff test is an exciting adjunct in the decision to proceed to surgery for prostatic obstruction. Patients predicted to be obstructed have an excellent likelihood of a good surgical outcome, yet 30% of those shown not to be obstructed will still do well. Whilst numbers in our study are small, outcomes compare favourably with published results on invasive urodynamic methods.

Incisión transuretral de la próstata: una alternativa de tratamiento de la hiperplasia prostática obstructiva / Trans-urethral incisión of the prostate: an alternative for treatment of obstructive prostatic hyperplasia

La hiperplasia prostática benigna (HPB) es un problema común en el varón senil. La HPB es el crecimiento prostático estromal-glandular en varones con un efecto testicular hormonal asociado con la edad y que produce obstrución urinaria conocida como prostatismo. 50 por ciento de varones con evidencia histológica de HPB evolucionarán a una obstrucción clínica y 25 por ciento tendrá que recibir algún tipo de tratamiento para sus síntomas. Este estudio valoró hombres con prostatismo asociado a HPB con un bajo volumen de zona transicional (ZT), y la utilidad de la incisión transuretral de próstata (ITUP), al compararse con varones en vigilancia y otros que recibieron tratamiento con bloqueadores alfa. Material y métodos. Doce hombres fueron sometidos a ITUP después de evaluación con la puntuación de la AUA, índice de calidad de vida y tasa de flujo máximo y se compararon los resultados con 10 pacientes que recibieron bloqueadores alfa y otro grupo de 10 pacientes que se vigilaron en un tiempo de 24 semanas, cada grupo con una ZT prostática de 15 cc o menor. Resultados. Los pacientes sometidos a ITUP obtuvieron los beneficios de esta modalidad incrementando la tasa de flujo máximo 4.93 ml/s, los pacientes con bloqueadores alfa incrementaron 4.36 ml/s, y los pacientes vigilados sólo incrementaron 1.8 ml/s, la puntuación de la AUA disminuyó 10.4 puntos en los pacientes sometidos a ITUP, en los pacientes con bloqueadores alfa disminuyó 3.8 puntos y en los pacientes vigilados se incrementó 1.5, el índice de calidad de vida disminuyó 2.5 puntos en los pacientes sometidos a ITUP, 1.6 en los que recibieron bloqueadores alfa y 0.2 en los pacientes vigilados. Conclusiones. La ITUP es una excelente alternativa de tratamiento de la BPB con bajo volumen de ZT (< de 15 cc), con buenos resultados a mediano plazo valorando lo anterior con la puntuación de síntomas de la AUA, índice de calidad de vida y tasa de flujo máximo